Full abstracts accepted as poster presentations will also be included in the special CTAD edition of the Journal of Prevention of Alzheimer’s Disease (JPAD), the official journal of the CTAD ...
Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...
GlobalData on MSN10h
MSD’s Phase III trial of head and neck cancer treatment meets primary endpointKEYTRUDA’s safety profile in this trial was found to be in line with previous studies, without any new safety concerns ...
Istaroxime is a novel first-in-class investigational therapy that is intended to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining ...
Clearside eye disease candidate aces exam in pursuit of Roche's Vabysmo and Regeneron, Bayer's Eylea
A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational ...
GlobalData on MSN8h
4C Medical enrols first patients in pivotal mitral valve trialUS-based 4C Medical has enrolled the first patients in a pivotal trial for its transcatheter mitral valve replacement (TMVR) ...
While their area of research is similar, Ambros and Ruvkun haven’t worked together since they were postdoctoral fellows in H. Robert Horvitz’s laboratory, who won the 2002 Nobel Prize in Physi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback